128 related articles for article (PubMed ID: 30967495)
1. LSINCT5 predicts unfavorable prognosis and exerts oncogenic function in osteosarcoma.
He W; Lu M; Xiao D
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30967495
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LSINCT5 predicts negative prognosis and exhibits oncogenic activity in gastric cancer.
Xu MD; Qi P; Weng WW; Shen XH; Ni SJ; Dong L; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Medicine (Baltimore); 2014 Dec; 93(28):e303. PubMed ID: 25526476
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LSINCT5 acts as an oncogene via increasing EZH2-induced inhibition of APC expression in osteosarcoma.
Kong D; Li C; Yang Q; Wei B; Wang L; Peng C
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):193-197. PubMed ID: 30420287
[TBL] [Abstract][Full Text] [Related]
4. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
Chen S; Li W; Guo A
Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
[TBL] [Abstract][Full Text] [Related]
5. GAPLINC is a predictor of poor prognosis and regulates cell migration and invasion in osteosarcoma.
Liao S; Zhou S; Wang C
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30177521
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG20 is associated with clinical progression and enhances cell migration and invasion in osteosarcoma.
Zhang J; Ju C; Zhang W; Xie L
IUBMB Life; 2018 Nov; 70(11):1115-1121. PubMed ID: 30120876
[TBL] [Abstract][Full Text] [Related]
7. LncRNA WWOX‑AS1 inhibits the proliferation, migration and invasion of osteosarcoma cells.
Qu G; Ma Z; Tong W; Yang J
Mol Med Rep; 2018 Jul; 18(1):779-788. PubMed ID: 29845204
[TBL] [Abstract][Full Text] [Related]
8. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
[TBL] [Abstract][Full Text] [Related]
10. LncRNA CBR3-AS1 predicts unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
Zhang Y; Meng W; Cui H
Biomed Pharmacother; 2018 Jun; 102():169-174. PubMed ID: 29554595
[TBL] [Abstract][Full Text] [Related]
11. Long Stress Induced Non-Coding Transcripts 5 (LSINCT5) Promotes Hepatocellular Carcinoma Progression Through Interaction with High-Mobility Group AT-hook 2 and MiR-4516.
Li O; Li Z; Tang Q; Li Y; Yuan S; Shen Y; Zhang Z; Li N; Chu K; Lei G
Med Sci Monit; 2018 Nov; 24():8510-8523. PubMed ID: 30472720
[TBL] [Abstract][Full Text] [Related]
12. A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth.
Liu SH; Zhu JW; Xu HH; Zhang GQ; Wang Y; Liu YM; Liang JB; Wang YX; Wu Y; Guo QF
Mol Cell Biochem; 2017 Jun; 430(1-2):47-56. PubMed ID: 28190168
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of lncRNA HULC indicates a poor prognosis and promotes cell metastasis in osteosarcoma.
Sun XH; Yang LB; Geng XL; Wang R; Zhang ZC
Int J Clin Exp Pathol; 2015; 8(3):2994-3000. PubMed ID: 26045809
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
15. LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma.
Wang Y; Zhao Z; Zhang S; Li Z; Li D; Yang S; Zhang H; Zeng X; Liu J
J Cell Biochem; 2018 Nov; 119(10):8481-8489. PubMed ID: 29987852
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-27a promotes proliferation, migration and invasion by targeting MAP2K4 in human osteosarcoma cells.
Pan W; Wang H; Jianwei R; Ye Z
Cell Physiol Biochem; 2014; 33(2):402-12. PubMed ID: 24556602
[TBL] [Abstract][Full Text] [Related]
17. LSINCT5: A Novel lncRNA in Cancers.
Qiu X; Chen J
Curr Med Chem; 2023; 30(39):4409-4420. PubMed ID: 36734894
[TBL] [Abstract][Full Text] [Related]
18. LncRNA BDNF-AS is associated with the malignant status and regulates cell proliferation and apoptosis in osteosarcoma.
Huang Q; Yang J; He X; Shi S; Xing S
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352834
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma.
Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
Biomed Pharmacother; 2018 Feb; 98():899-906. PubMed ID: 29571260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
